|
|
|
International Clinical Trials
|
Over the past 10 years, the market value of the global pharmaceutical industry has more than doubled to $951 billion. In 2015, markets outside the US and Western Europe accounted for $362 billion, comprising approximately 38% of the total worldwide value (1).
There is no doubt about it: the healthcare industry has become truly global, and clinical trials are being delocalised to match. In fact, between 2005 and 2012, the largest annual growth in clinical trials occurred in Asian (30%) and Latin American/Caribbean (12%) regions (2).
As the clinical trials industry expands into emerging countries, protocols developed in one country are increasingly implemented in culturally and linguistically different locations. Competent and compliant translation is, therefore, becoming more necessary than ever in order to ensure that clinical trial protocols (CPTs) are correctly followed, and that participants can confidently understand and consent to them.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
YHEC announced appointment of Stuart Mealing as Associate Director of Health Technology Assessment
YHEC is pleased to announce the appointment of Stuart Mealing as Associate Director of Health Technology Assessment. Stuart will be leading the YHEC economic evaluation and modelling team. Stuart has a Master’s degree in operational research from the University of Lancaster Business School and a post-graduate certificate in international business management from Smurfit Business School, Dublin.
More info >> |
|
 |
White Papers |
 |
|
Conveying Medical Guidance in Clinical Trials – A Survey
Europital Medical Consultancy
With the incremental demand for proactive safety surveillance throughout the conduct of clinical trials, the role of Medical Management is at the fore in ensuring the safety and wellbeing of the participants. The complex responsibilities of a Medical Monitor (MM) starts from the design and development phase, through to study close out. Understanding the principle behind the protocol and the prospective medical solution the study would deliver forms the bloodline for the MM role. Often, the MM is the face of contact for both the site personnel and the study team members with regard to medical, safety and scientific issues within the project.
When it comes to medical guidance, the communication channel used to deliver solutions contributes to a large extent in effectively managing decisive situations. Our previous study on acquiring medical guidance from an operations team perspective revealed that e-mails were the most used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical guidance delivery, we designed a survey to study the existing trend and constraints in this communication chain management, as outlined here.
More info >> |
|
 |
Industry Events |
 |
Cell Therapy Manufacturing & Gene Therapy Congress
6-7 December 2017, RAI, Amsterdam
Bringing together 300+ leaders and key influencers from
pharma and biotech companies on 6 - 7
December 2017 in Amsterdam, Cell
Therapy Manufacturing & Gene Therapy Congress will provide you with the
latest advice for driving manufacturing and commercialisation through direct
access to transforming innovative research to prosperous cell & gene
manufacturing.
More info >> |
|
|
